T-NeuroDx to Present AlzheimerGuard™ Human Data at AAIC 2026
Immune Biomarker Targets Alzheimer’s Trial Enrichment and Early Clinical Detection ALBUQUERQUE, NM, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- T-NeuroDx, a biotechnology company developing novel immune-based diagnostics for early …